"Receptors, CXCR" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemokine receptors that are specific for CXC CHEMOKINES.
| Descriptor ID |
D054387
|
| MeSH Number(s) |
D12.776.543.750.695.160.500 D12.776.543.750.705.852.125.500
|
| Concept/Terms |
Receptors, CXCR- Receptors, CXCR
- CXC Chemokine Receptors
- Chemokine Receptors, CXC
- Receptors, CXC Chemokine
- CXC Chemokine Receptor
- Chemokine Receptor, CXC
- Receptor, CXC Chemokine
- CXCR Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, CXCR".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CXCR [D12.776.543.750.695.160.500]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CXCR [D12.776.543.750.705.852.125.500]
Below are MeSH descriptors whose meaning is more specific than "Receptors, CXCR".
This graph shows the total number of publications written about "Receptors, CXCR" by people in this website by year, and whether "Receptors, CXCR" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, CXCR" by people in Profiles.
-
A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models. Mol Ther. 2018 05 02; 26(5):1354-1365.
-
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models. Int J Cancer. 2018 05 15; 142(10):2163-2174.
-
Developmental expression patterns of chemokines CXCL11, CXCL12 and their receptor CXCR7 in testes of common marmoset and human. Cell Tissue Res. 2015 Sep; 361(3):885-98.
-
Profiling of Cxcl12 receptors, Cxcr4 and Cxcr7 in murine testis development and a spermatogenic depletion model indicates a role for Cxcr7 in controlling Cxcl12 activity. PLoS One. 2014; 9(12):e112598.
-
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not. Cell Mol Immunol. 2015 Jul; 12(4):474-82.
-
Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition. Oncotarget. 2014 Oct 15; 5(19):8947-58.
-
CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis. Arterioscler Thromb Vasc Biol. 2014 Jul; 34(7):1422-8.
-
The chemokine receptor CXCR6 contributes to recruitment of bone marrow-derived fibroblast precursors in renal fibrosis. Kidney Int. 2014 Aug; 86(2):327-37.
-
Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-a, interferon-? and interleukin-12. Immunology. 2013 Sep; 140(1):98-110.
-
CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol. 2011 Oct; 22(10):1876-86.